000			01392na a2200241 4500
999			_c2933 _d2933
003			H12O
005			20190820125539.0
008			130622s2012 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aCortés-Funes Castro, Hernán _91181 _eOncología Médica
100			_9431 _aGrávalos Castro, Cristina _eOncología Médica
245	0	2	_aA randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer. _h[artículo]
260			_bClinical & Translational Oncology, _c2012
300			_a14(8):606-12.
500			_aFormato Vancouver: Gravalos C, Salut A, García-Girón C, García-Carbonero R, León AI, Sevilla I, et al. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer. Clin Transl Oncol. 2012 Aug;14(8):606-12.
501			_aPMID: 22855138
504			_aContiene 34 referencias
520			_aThe aim of this study was to compare TOMOX versus FOLFOX4 as first-line treatment of advanced colorectal cancer (CRC).
710			_9303 _aServicio de Oncología Médica
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/2/pc2933.pdf _ySolicitar documento
942			_n0 _2ddc _cART